Background
Distinct inflammatory profiles have been associated with increased prevalence of cardiovascular disease (CVD) in people with HIV (PWH). Alterations in tryptophan metabolism through the kynurenine pathway (KP) have also been observed in PWH and are associated with CVD. We aimed to explore relationships between KP metabolites and inflammatory profiles of PWH.
Methods
In the All-Ireland Infectious Diseases (AIID) cohort, we previously identified 3 distinct inflammatory clusters using principal components analysis and hierarchical clustering on 38 plasma biomarkers. Cluster 3 (C3), denoted by higher markers of T-cell inflammation and gut endothelial dysfunction, was associated with 7-fold increased prevalence of CVD.
Within this cohort, we matched (1:1:1) participants in C3 to Cluster 1 (C1) (non-inflamed) and Cluster 2 (C2) (systemically inflamed) by sex-at-birth, age and ethnicity using propensity score with the nearest neighbor method.
We measured the relative concentrations of ten KP metabolites (AU/mL) in plasma by UHPLC-MS/MS. We used Kruskall-Wallis to identify differences between groups followed by Dunn’s multiple comparison test (with correction) to determine specific pairwise differences between clusters. Data are median (IQR) unless specified.
Results
We included 87 PWH, 29 from each cluster. Overall, 34.5% were female, 52.3% Caucasian, age 45 (39.5-49) years, time since HIV diagnosis 10 (5-16) years. Jaccard index was 0.9. Clusters did not differ on age, sex or ethnicity. Compared to C1, PWH in C3 had significantly higher CD4/CD8 ratio and lower total and LDL cholesterol.
Of the 10 KP metabolites, four anti-inflammatory metabolites of the kynurenic acid branch of the KP were significantly downregulated in C3; specifically kynurenate [C3; 0.82 (1.26 – 0.6) vs. C1; 1.22 (1.41 – 1.04), p=0.01], 8-methoxy-kynurenate [C3; 0.68 (0.91 – 0.42) vs C1; 1.22 (1.98 – 0.61), p=0.03], xanthurenate [C3; 0.63 (1.09 – 0.4) vs C1; 1.19 (1.79 – 0.77), p=0.03], involved in vitamin B3 synthesis, and N-acetyl-kynurenine [C3; 0.68 (0.98 – 0.49) vs C1; 1.47 (2.4 – 0.67), p=0.004], an intermediate of NAD+ synthesis (Figure). All four downregulated KP metabolites correlated closely (all p<0.02).
Conclusions
Proinflammatory profiles associated with higher prevalent CVD in PWH link to coordinated downregulation in anti-inflammatory metabolites in the KP, providing insights into the pathogenesis of CVD in PWH and supporting a role for precision medicine to identify those PWH most at risk of CVD.